We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC DRUGMAKERS BEMOAN DRUG 'CARVE-OUT' INITIATIVES
GENERIC DRUGMAKERS BEMOAN DRUG 'CARVE-OUT' INITIATIVES
April 8, 2004
The brand pharmaceutical lobby has been successful in persuading legislators in 24 states to amend Medicaid laws to exempt expensive therapeutic drug classes from substitution rules requiring doctors to prescribe lower-priced alternatives, according to a generic drug executive.